Experimental vaccination of sheep against hydatid cyst using EG95 recombinant vaccine
Authors
Abstract:
Vaccination of livestock with effective vaccine could be one of the control methods for hydatid cyst. In this study a new recombinant vaccine (Eg95) from New Zealand was prepared and used. Thirty health sheep from the same race and identical age and sex were selected. There was no history of any past vaccination or disease in selected animals. Animals were randomly categorized to four groups. One group including ten sheep received two times vaccination and each time 50 microgram with two weeks interval. Another group (10 sheep) received physiological saline without vaccine. Five weeks after second vaccination both groups were challenged with 3500 freshly Echinococcus granulosus (Iran isolate, dog/sheep cycle) eggs intraruminally. Animals, in third and fourth groups, received vaccine and physiological saline respectively. Third and fourth groups did not challenge and kept for vaccine adverse effects or natural infection control. Anti-Eg95 antibody titer was evaluated with ELISA before and two weeks after each vaccination. Optical density (OD) rates for all groups were less than 0.1 before vaccination. A 40 fold increase in OD rates of vaccinated groups was seen 2 weeks after second vaccination. Animals under the study were fully surveyed. Results indicated 98% protection in vaccinated group when they were necropsied 12 months after challenge .The EG95 vaccine can be produced on an industrial scale and can be further use for clinical trial in Iran.
similar resources
experimental vaccination of sheep against hydatid cyst using eg95 recombinant vaccine
vaccination of livestock with effective vaccine could be one of the control methods for hydatid cyst. in this study a new recombinant vaccine (eg95) from new zealand was prepared and used. thirty health sheep from the same race and identical age and sex were selected. there was no history of any past vaccination or disease in selected animals. animals were randomly categorized to four groups. o...
full textExperimental vaccination of sheep and cattle against tick infestation using recombinant 5′-nucleotidase
Limited prior evidence suggests that 5'-nucleotidase, an ectoenzyme principally located in the Malpighian tubules of the tick Rhipicephalus (Boophilus) microplus, could be an effective antigen in an anti-tick vaccine. To assess this, recombinant 5'-nucleotidase was expressed in Escherichia coli and used in vaccination trials with both sheep and cattle. Vaccinated sheep were challenged with fres...
full textVaccination of Chicks with an Experimental Oil-emulsion Vaccine against Infectious Bursal Disease Virus
full text
Correlation between age of sheep and structural changes of sheep hydatid cyst
BACKGROUD: Naturally, the prevalence of hydatid cyst of sheep increase with age and accompany with structural changes. OBJECTIVES: The aim of the present study was to determine prevalence of hydatid cyst in sheep and its structure with age. METHODS: During 2009, 786 sheep in different age groups (1 to 6“ |years) slaughtered at Babol abattoir, Mazanderan province were examined for hydatid cyst ...
full textPurification and Immunobiochemical Characterization of Sheep Hydatid Cyst Fluid Antigen
In the present study, sheep crude hydatid cyst fluid antigen (SCHCFA) was prepared by ammonium sulfate precipitation, centrifugation and dialysis. SDS-PAGE of SCHCFA showed seven polypeptides of 72.8 kDa, 66.5 kDa, 60.2 kDa, 41 kDa, 25.1 kDa, 19 kDa and 8 kDa when stained with Coomassie briliant Blue R-250. The initial part of the ascending loop of the first peak (PI) when resolved by gel filtr...
full textProtection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
Rift Valley fever (RVF) is an epizootic viral disease of sheep that can be transmitted from sheep to humans, particularly by contact with aborted fetuses. A capripoxvirus (CPV) recombinant virus (rKS1/RVFV) was developed, which expressed the Rift Valley fever virus (RVFV) Gn and Gc glycoproteins. These expressed glycoproteins had the correct size and reacted with monoclonal antibodies (MAb) to ...
full textMy Resources
Journal title
volume 63 issue 2
pages 29- 34
publication date 2008-07-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023